West Pharmaceutical Services, Inc. Common Stock (WST)
Healthcare › Surgical & Medical Instruments & Apparatus
Price History
Feb 9, 2026 — May 24, 2026Investment Snapshot
- Trading 285% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 6/9 — moderate financial health
- ROE of 16.7% — good return on equity
- Revenue growing at 6% annually
West Pharmaceutical Services, Inc. Common Stock (WST) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the NYSE , with a market capitalisation of $22.4 billion . Key value metrics: P/E ratio 44.7, P/B ratio 7.48, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
West Pharmaceutical Services, Inc. Common Stock — Fundamental Analysis Summary
West Pharmaceutical Services, Inc. Common Stock (WST) is currently trading 285% above its Graham Number of $82.13, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 44.7x.
On financial health, WST shows a moderate Piotroski F-Score of 6/9, and solid return on equity of 16.7% (sector average: -20.6%), and minimal leverage with a debt-to-equity ratio of 0.07.
StockPik's composite Value Score for WST is 49/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
WST reports a moderate gross margin of 35.2% (sector average: 40.1%) and a solid operating margin of 19.4%.
WST shows revenue growing at 6% year-over-year, with earnings growing at 0%.
WST pays a modest dividend yield of 0.3%.